Even in the context of lymphopenia, especially with COVID-19, patients demonstrate hyperactivation of CD8+, with a correspondent overaggressive response, including high levels of expression of NK-cell-related markers and increased cytotoxicity [23]. This evidence concerns the gene CD8A and COVID-19.